"Our study shows that the ability of old human muscle to be maintained and repaired by muscle stem cells can be restored to youthful vigor"

Clues To Reversing Aging Of Human Muscle Discovered

ScienceDaily (Sep. 30, 2009) — A study led by researchers at the University of California, Berkeley, has identified critical biochemical pathways linked to the aging of human muscle. By manipulating these pathways, the researchers were able to turn back the clock on old human muscle, restoring its ability to repair and rebuild itself.

The findings will be reported in the Sept. 30 issue of the journal EMBO Molecular Medicine, a peer-reviewed, scientific publication of the European Molecular Biology Organization.

"Our study shows that the ability of old human muscle to be maintained and repaired by muscle stem cells can be restored to youthful vigor given the right mix of biochemical signals," said Professor Irina Conboy, a faculty member in the graduate bioengineering program that is run jointly by UC Berkeley and UC San Francisco, and head of the research team conducting the study. "This provides promising new targets for forestalling the debilitating muscle atrophy that accompanies aging, and perhaps other tissue degenerative disorders as well."

Young, healthy muscle (left column) appears pink and red. In contrast, the old muscle is marked by scarring and inflammation, as evidenced by the yellow and blue areas. This difference between old and young tissue occurs both in the muscle's normal state and after two weeks of immobilization in a cast. Exercise after cast removal did not significantly improve old muscle regeneration; scarring and inflammation persisted, or worsened in many cases. (Credit: Photo by Morgan E. Carlson and Irina M. Conboy, UC Berkeley)

via Clues To Reversing Aging Of Human Muscle Discovered.

Eli Lilly is now the sole manufacturer of rBGH — the artificial growth hormone given to dairy cows that increases people’s risk of cancer. Eli Lilly also manufactures breast cancer treatment medications and a pill that “reduces the risk” of breast cancer. Eli Lilly is milking cancer. Tell them to stop making rBGH.

[vodpod id=Groupvideo.3533193&w=225&h=150&fv=clip_id%3D6675967%26server%3Dvimeo.com%26autoplay%3D0%26fullscreen%3D1%26md5%3D0%26show_portrait%3D0%26show_title%3D0%26show_byline%3D0%26context%3Duser%3A2318200%26context_id%3D%26force_embed%3D0%26multimoog%3D%26color%3D00ADEF%26force_info%3Dundefined]

ALS Stem Cell Trial Gets FDA Go Ahead The US Food and Drug Administration (FDA) said the first clinical trial to test a new stem cell treatment for the fatal neurodegenerative disease ALS (amyotrophic lateral sclerosis) this month (ALS) can go ahead.

via Google Reader (641).

WHAT ARE ALL OF THE STEM CELL STOCKS DOING?

To see a REAL TIME list of these stocks on YAHOO FINANCE click here: STEM CELL STOCKS - REAL TIME


To see a DAY WATCH list of these stocks on YAHOO FINANCE click here: STEM CELL STOCKS - DAY WATCH

To see a BASIC list of these stocks on YAHOO FINANCE click here: STEM CELL STOCKS - BASIC

To see a SUMMARRY list of these stocks on YAHOO FINANCE click here: STEM CELL STOCKS - SUMMARRY

These are the stocks currently covered:

ACTC.PK ALXN AOLS.OB ARIA ASTM BHRT BMSN.OB BTIM.OB CCEL.OB CELG CRIS CUR DNDN GERN IART INCR.OB ISCO.OB KOOL MCET.OB MEDS.PK OCHT.PK OSTE OSIR PKI PPMD.PK PSTI SPPI STEM VODG.OB

Changes to this list may occur without notice.  Information provided by YAHOO FINANCE is for information and educational purposes only.  All stock prices and trades should be verified b a certified broker.

thanks to the The Stem Cell Stock List.

Web site on Johns Hopkins stem cell research is launched September 28, 2009 By Gazette Contributor Filed under In Brief Share this story In conjunction with last week’s 2009 World Stem Cell Summit, co-hosted by Johns Hopkins and held in Baltimore, Johns Hopkins Medicine launched an interactive Web site on which its researchers and clinicians collectively describe their explorations into stem cell biology and engineering. The multimedia production, which went live Sept. 21 at www.hopkinsmedicine.org/stem_cell_research, emphasizes applications of stem cell technologies in regenerative medicine and underscores the collaborative effort that is fundamental to translational research. The site includes everything from a narrated timeline of stem cell research to a video feature of a Johns Hopkins patient, physician and bench scientist who are linked by stem cell research as it relates to Parkinson’s disease. Johns Hopkins experts also weigh in on state-of-the-art issues of ethics and safety as they apply to stem cells. via Web site on Johns Hopkins stem cell research is launched : The Gazette.